Endocrine and metabolic disturbances in Human Immunodeficiency Virus infection and the Acquired Immune Deficiency Syndrome

Endocrine Reviews

Volumn 17, Issue 5, 1996, Pages 518-532

  Sellmeyer, Deborah E ^b   Grunfeld, Carl ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANDROGEN; FOSCARNET; GLUCOCORTICOID; GLUCOSE; KETOCONAZOLE; LIPID; MAGNESIUM; MEGESTROL ACETATE; MINERALOCORTICOID; PENTAMIDINE; POTASSIUM ION; RIFAMPICIN; SODIUM ION; SULFONAMIDE; THYROID HORMONE; TRIMETHOPRIM;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DISEASE COURSE; GLUCOSE HOMEOSTASIS; GONAD DYSFUNCTION; HORMONAL REGULATION; HORMONAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LIPID METABOLISM; MINERAL BALANCE; NEUROIMMUNOLOGY; PRIORITY JOURNAL; REVIEW; THYROID TUMOR;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADRENAL GLANDS; FEMALE; GLUCOSE; HIV INFECTIONS; HIV WASTING SYNDROME; HOMEOSTASIS; HUMANS; LIPID METABOLISM; MALE; MINERALS; OVARY; PANCREAS; PITUITARY GLAND; TESTIS; THYROID GLAND;

EID: 0029973894     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.17.5.518     Document Type: Review

References (187)

1. Broder S, Merigan TC, Bolognesi D (eds) 1994 Textbook of AIDS Medicine. Williams & Wilkins, Baltimore, MD
2. Welch K, Finkbeiner W, Alpers CE, Blumenfeld W, Davis RL, Smuckler EA, Beckstead JH 1984 Autopsy findings in the acquired immune deficiency syndrome. JAMA 252:1152-1159
3. Spitzer RD, Chan JC, Marks JB, Valme BR, McKenzie JM 1991 Case report: hypothyroidism due to Pneumocystis carinii thyroiditis in a patient with acquired immunodeficiency syndrome. Am J Med Sci 302:98-100
4. Ragni MV, Dekker A, DeRubertis FR, Watson CG, Skolnick ML, Goold SD, Finikiotis MW, Doshi S, Myers DJ 1991 Pneumocystis carinii infection presenting as necrotizing thyroiditis and hypothyroidism. Am J Clin Pathol 95:489-493
5. Battan R, Mariuz P, Raviglione MC, Sabatini MT, Mullen MP, Poretsky L 1991 Pneumocystis carinii infection of the thyroid in a hypothyroid patient with AIDS: diagnosis by fine needle aspiration biopsy. J Clin Endocrinol Metab 72:724-726
6. McCarty M, Coker R, Claydon E 1992 Case report: disseminated pneumocystis carinii infection in a patient with the acquired immune deficiency syndrome casuing thyroid gland calcification and hypothyroidism. Clin Radiol 45:209-210
7. Guttler R, Singer PA 1993 Pneumocystis carinii thyroiditis. Report of three cases and review of the literature. Arch Intern Med 153: 393-396
8. Vijayakumar V, Bekerman C, Blend MJ, Pinsky S 1993 Role of Ga-67 citrate imaging in extrapulmonary pneumocystis in HIV positive patients. Clin Nucl Med 18:337-338
9. Drucker D, Bailey D, Rotstein L 1990 Thyroiditis as the presenting manifestation of disseminated extrapulmonary Pneumoncystis carinii infection. J Clin Endocrinol Metab 71:1663-1665
10. Patel A, Sowden D, Kemp R, D'Emden M, Perry-Keene D 1992 Pneumocystis thyroiditis. Med J Aust 156:136-137
11. Gallant J, Enriques R, Cohen KL, Hammers LW 1988 Pneumocystis carinii thyroiditis. Am J Med 84:303-306
12. Walts AE, Pitchon HE 1991 Pneumocystis carinii in FNA of the thyroid. Diagn Cytopathol 7:615-617
13. Frank TS, LiVolsi VA, Connor AM 1987 Cytomegalovirus infection of the thyroid in immunocompromised adults. Yale J Biol Med 60:1-8
14. Machac J, Mejatheim M, Goldsmith SJ 1985 Gallium-67 citrate uptake in cryptococcal thyroiditis in a homosexual male. J Nucl Med Allied Sci 29:283-285
15. Martinez-Ocana JC, Romen J, Llatjos M, Sirera G, Clotet B 1993 Goiter as a manifestation of disseminated aspergillosis in a patient with AIDS. Clin Infect Dis 17:953-954
16. Krauth PH, Katz J 1987 Kaposi's sarcoma involving the thyroid in a patient with AIDS. Clin Nucl Med 12:848-849
17. Mollison LC, Mijch A, McBride G, Dwyer B 1991 Hypothyroidism due to destruction of the thyroid by Kaposi's sarcoma. Rev Infect Dis 13:826-827
18. Wartofsky L, Burman KD 1982 Alterations in thyroid function in patients with systemic illnesses: the euthyroid sick syndrome. Endoer Rev 3:164-217
19. Vagenakis AG, Portnay GI, O'Brian JT, Rudolph M, Arky RA, Ingbar SH, Bravennan LE 1977 Effect of starvation on the production and metabolism of thyroxine and triiodothyronine in euthyroid obese patients. J Clin Endocrinol Metab 45:1305-1309
20. Eisenstein Z, Hagg S, Vagenakis AG, Fang SL, Ransil B, Burger A, Balsam A, Braverman LE, Ingbar SH 1978 Effect of starvation on the production and peripheral metabolism of 3,3′,5′-triiodothyronine in euthyroid obese subjects. J Clin Endocrinol Metab 47:889-893
21. Gardner DF, Kaplan MM, Stanley CA, Utiger RD 1979 Effect of tri-iodothyronine replacement on the metabolic and pituitary responses to starvation. N Engl J Med 300:579-584
22. 3 administration on muscle protein catabolism during fasting as measured by 3-methylhistidine excretion. Metabolism 28:805-813
23. Dobs AS, Dempsy MA, Ladenson PW, Polk BF 1988 Endocrine disorders in men infected with the human immunodeficiency virus. Am J Med 84:611-616
24. Hommes MJT, Romijn JA, Godfried MH, Schattenkerk E, Buurman WA, Endert E, Sauerwein HP 1990 Increased resting energy expenditure in human immunodeficiency virus-infected men. Metabolism 39:1186-1190
25. Hommes MJT, Romijn JA, Endert E, Adriaanse R, Brabant G, Schattenkerk E, Wiersinga WM, Sauerwein HP 1993 Hypothyroid-like regulation of the pituitary-thyroid axis in stable human immunodeficiency virus infection. Metabolism 42:556-561
26. Raffi F, Brisseau JM, Planchon B, Remi JP, Barrier JH, Grolleau JY 1991 Endocrine function in 98 HIV infected patients: a prospective study. AIDS 5:729-733
27. Merenich JA, McDermott MT, Asp AA, Harrison SM, Kidd GS 1990 Evidence of endocrine involvement early in the course of human immunodeficiency virus infection. J Clin Endocrinol Metab 70:566-570
28. LoPresti JS, Fried JC, Spencer CA, Nicoloff JT 1989 Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome. Ann Intern Med 110:970-975
29. Tang WW, Kaptein EM 1989 Thyroid hormone levels in the acquired immunodeficiency syndrome (AIDS) or AIDS-related complex. West J Med 151:627-631
30. Fried JC, LoPresti JS, Micon M, Bauer M, Tuchschmidt JA, Nicoloff JT 1990 Serum triiodothyronine values: prognostic indicators of acute mortality due to Pneumocystis carinii pneumonia associated with the acquired immunodeficiency syndrome. Arch Intern Med 150:406-409
31. Grunfeld C, Pang M, Doerrler W, Jensen P, Shimizu L, Feingold KR, Cavalieri R 1993 Indices of thyroid function and weight loss in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Metabolism 42:1270-1276
32. Lambert M, Zech F, DeNayer P, Jamez J, Vandercam B 1990 Elevation of serum thyroxine binding globulin (but not of cortisol binding globulin and sex hormone-binding globulin) associated with the progression of human immunodeficiency virus infection. Am J Med 89:748-751
33. Bourdoux PR, DeWit SA, Servais GM, Clumeck N, Bonnyns MA 1991 Biochemical thyroid profile in patients infected with the human immunodeficiency virus. Thyroid 1:147-149
34. Olivieri A, Sorcini M, Fazzini C, Gilardi E, Sun Y, Medda E, Grandolfo M, Tossini G, Natili S, Giola C, Narciso P, Visco G, Carta S 1993 Thyroid hypofunction related with the progression of human immunodeficiency virus infection. J Endocrinol Invest 16: 407-413
35. Stouthard JML, van der Poll T, Endert E, Bakker PJ, Veenhof CH, Sauerwein HP, Romijn JA 1994 Effects of acute and chronic interleukin-6 administration on thyroid metabolism in humans. J Clin Endocrinol Metab 79:1342-1346
36. van der Poll T, Romjin JA, Wiersinga WM, Sauerwein HP 1990 Tumor necrosis factor: a putative mediator of the sick euthyroid syndrome in man. J Clin Endocrinol Metab 71:1567-1572
37. Grunfeld C, Kotler DP, Shigenaga JK, Doerrler W, Tierney A, Wang J, Pierson RN, Feingold KR 1991 Circulating interferon-α levels and hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 90:154-162
38. Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR 1992 Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 74: 1045-1052
39. Hellerstein MK, Grunfeld C, Wu K, Christiansen M, Kaempfer S, Kletke C, Shackleton CH 1993 Increased de novo hepatic lipogenesis in human immunodeficiency virus infection. J Clin Endocrinol Metab 76:559-565
40. Ohnhaus EE, Burgi H, Burger A, Studer H 1981 The effect of antipyrine phenobarbital, rifampicin on thyroid hormone metabolism in man. Eur J Clin Invest 11:381-387
41. Ohnhaus EE, Studer H 1980 The effect of different doses of rifampicin on thyroid hormone metabolism [proceedings]. Br J Clin Pharmacol 9:285P-286P
42. Isley WL 1987 Effect of rifampin therapy on thyroid function tests in a hypothyroid patient on replacement L-thyroxine. Ann Intern Med 107:517-518
43. Klatt EC, Shibata D 1988 Cytomegalovirus infection in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 112: 540-544
44. Guarda LA, Luna MA, Smith L, Mansell PWA, Gyorkey F, Roca AN 1984 Acquired immune deficiency syndrome: postmortem findings. Am J Clin Pathol 81:549-557
45. Bricaire F, Marche C, Zoubi D, Regnier B, Saimot AG 1988 Adrenocortical lesions and AIDS. Lancet 1:881
46. Laulund S, Visfeldt J, Klinken L 1986 Patho-anatomical studies in patients dying of AIDS. Acta Pathol Microbiol Immunol Scand 94:201-221
47. Pillay D, Lipman MCI, Lee CA, Johnson MA, Griffiths PD, McLaughlin JE 1993 A clinico-pathological audit of opportunistic viral infections in HIV-infected patients. AIDS 7:969-974
48. Glasgow BJ, Steinsapir KD, Anders K, Layfield LJ 1985 Adrenal pathology in the acquired immunodeficiency syndrome. Am J Clin Pathol 84:594-597
49. Drew WL 1988 Cytomegalovirus infection in patients with AIDS. J Infect Dis 158:449-456
50. Tapper ML, Rotterdam HZ, Lerner CW, Al'Khafaji K, Seitzman PA 1984 Adrenal necrosis in the acquired immunodeficiency syndrome. Ann Intern Med 100:239-241
51. Pulakhandam U, Dincsoy HP 1990 Cytomegaloviral adrenalitis and adrenal insufficiency in AIDS. Am J Clin Pathol 93:651-656
52. Bleiweiss IJ, Pervez NK, Hammer GS, Dikman SH 1986 Cytomegalovirus-induced adrenal insufficiency and associated renal cell carcinoma in AIDS. Mt Sinai J Med 53:676-679
53. Angulo JC, Lopez JI, Flores N 1994 Lethal Cytomegalovirus adrenalitis in a case of AIDS. Scand J Urol Nephrol 28:105-106
54. Greene LW, Cole W, Greene JB, Levy B, Louie E, Raphael B, Waitkevicz J, Blum M 1984 Adrenal insufficiency as a complication of the acquired immunodeficiency syndrome. Ann Intern Med 101:497-498
55. Guenthner EE, Rabinowe SL, Van Niel A, Naftilan A, Dluhy RG 1984 Primary Addison's disease in a patient with the acquired immunodeficiency syndrome. Ann Intern Med 100:847-848
56. Findling JW, Buggy BP, Gilson IH, Brummitt CF, Bernstein BM, Raff H 1994 Longitudinal evaluation of adrenocortical function in patients infected with the human immunodeficiency virus. J Clin Endocrinol Metab 79:1091-1096
57. Verges B, Chavanet P, Desgres J, Vaillant G, Waldner A, Brun JM, Putelat R 1989 Adrenal function in HIV infected patients. Acta Endocrinol (Copenh) 121:633-637
58. Villette JM, Bourin P, Doinel C, Mansour I, Fiet J, Boudou P, Dreux C, Roue R, Debord M, Levi F 1990 Circadian variations in plasma levels of hypophyseal, adrenocortical and testicular hormones in men infected with human immunodeficiency virus. J Clin Endocrinol Metab 70:572-577
59. Membreno L, Irony I, Dere W, Klein R, Biglieri EG, Cobb E 1987 Adrenocortical function in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 65:482-487
60. Hilton CW, Harrington PT, Prasad C, Svec F 1988 Adrenal insufficiency in the acquired immunodeficiency syndrome. South Med J 81:1493-1495
61. Christeff N, Gharakhanian S, Thobie N, Rozenbaum W, Nunez EA 1992 Evidence for changes in adrenal and testicular steroids during HIV infection. J Acquir Immune Defic Syndr 5:841-846
62. Biglino A, Limone P, Forno B, Pollono A, Cariti G, Molinatti GM, Gioannini P 1995 Altered adrenocorticotropin and cortisol response to corticotropin-releasing hormone in HIV-1 infection. Eur J Endocrinol 133:173-179
63. Darling G, Goldstein DS, Stull R, Gorschboth CM, Norton JA 1989 Tumor necrosis factor: immune endocrine interaction. Surgery 106:1155-1160
64. Woloski BM, Smith EM, Meyer WJ, Fuller GM, Blalock JE 1985 Corticotropin-releasing activity of monokines. Science 230:1035-1037
65. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W 1987 Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 238:522-524
66. Rivier C 1990 Role of endotoxin and interleukin-1 in modulating ACTH, LH, and sex steroid secretion. Adv Exp Med Biol 274:295-301
67. Rivier C, Chizzonite R, Vale W 1989 In the mouse, the activation of the hypothalamic-pituitary-adrenal axis by a lipopolysaccaride (endotoxin) is mediated through interleukin-1. Endocrinology 125: 2800-2805
68. Sibbald WJ, Short A, Cohen MP, Wilson RF 1977 Variations in adrenocortical responsiveness during severe bacterial infections. Ann Surg 186:29-33
69. Azar ST, Melby JC 1993 Hypothalamic-pituitary-adrenal function in non-AIDS patients with advanced HIV infection. Am J Med Sci 305:321-325
70. Dackis CA, Gurpegui M, Pottash ALC, Gold MS 1982 Methadone induced hypoadrenalism, Lancet 1:1167
71. Norbiato G, Bevilaxqua M, Bago T, Moroni M 1992 Cortisol resistance in acquired immunodeficiency syndrome. J Clin Endocrinol Metab 74:608-613
72. Norbiato G, Bevilacqua M, Vago T, Baldi G, Castellia L, Righini V, Glucocorticoid resistance in the acquired immunodeficiency syndrome. Effects on the immunosystem. Program of the 76th Annual Meeting of The Endocrine Society, Anaheim, CA, 1994 (Abstract)
73. Pont A, Graybill JR, Craven PC, Gagiani JN, Dismukes WE, Reitz RE, Stevens DA 1984 High-dose ketoconazole therapy and adrenal and testicular function in humans. Arch Intern Med 144:2150-2153
74. Loprinzi CL, Jensen MD, Jiang N, Schaid DJ 1992 Effect of megestrol acetate on the human pituitary-adrenal axis. Mayo Clin Proc 67:1160-1162
75. Ediger SK, Isley WL 1988 Rifampicin-induced adrenal insufficiency in the acquired immunodeficiency syndrome: difficulties in diagnosis and treatment. Postgrad Med J 64:405-406
76. Kyriazopoulou V, Parparousi O, Vagenakis AG 1984 Rifampicin-induced adrenal crisis in addisonian patients receiving corticosteroid replacement. J Clin Endocrinol Metab 59:1204-1206
77. Wisniewski TL, Hilton CW, Morse EV, Svec F 1993 The relationship of serum DHEAS and cortisol levels to measures of immune function in human immunodeficiency virus-related illness. Am J Med Sci 305:79-83
78. Mulder JW, Jos Frissen PH, Krijnen P, Endert E, de Wolf F, Goudsmit J, Masterson JG, Lange JMA 1992 Dehydroepiandrosterone as predictor for progression to AIDS in asymptomatic human immunodeficiency virus-infected men. J Infect Dis 165:413-418
79. Jacobson MA, Fusaro RE, Galmarini M, Lang W 1991 Decreased serum dehydroepiandrosterone is associated with an increased progression of human immunodeficiency virus infection in men with CD4 cell counts of 200-499. J Infect Dis 164:864-868
80. Honour J, Schneider MA, Miller RF 1995 Low adrenal androgens in men with HIV infection and the acquired immunodeficiency syndrome. Horm Res 44:35-39
81. Henderson E, Yang J, Schwartz A 1992 Dehydroepiandrosterone (DHEA) and synthetic DHEA analogs are modest inhibitors of HIV-1 III-B replication. AIDS Res Hum Retroviruses 8:625-631
82. Guy RJC, Turber Y, Davidson RN, Finnerty G, MacGregor GA, Wise PH 1989 Mineralocorticoid deficiency in HIV infection. Br Med J 298:496-497
83. Kalin MF, Poretsky L, Seres DS, Zumoff B 1987 Hyporeninemic hypoaldosteronism associated with acquired immune deficiency syndrome. Am J Med 82:1035-1038
84. Hsu I, Wordell CJ 1995 Hyperkalemia and high-dose trimethoprim/sulfamethoxazole. Ann Pharmacother 29:427-429
85. Appel GB, Neu HC 1977 The nephrotoxicity of antimicrobial agents (third of three parts). N Engl J Med 296:784-787
86. Schambelan M, Sebastian A, Biglieri EG 1980 Prevalence, pathogenesis, and functional significance of aldosterone deficiency in hyperkalemic patients with chronic renal insufficiency. Kidney Int 17:89-101
87. Lachaal M, Venuto RC 1989 Nephrotoxicity and hyperkalemia in patients with acquired immunodeficiency syndrome treated with pentamidine. Am J Med 87:260-263
88. Gearhart MO, Sorg TB 1993 Foscarnet-induced severe hypomagnesemia and other electrolyte disorders. Ann Pharmacother 27: 285-288
89. Youle MS, Clarbour J, Gazzard B, Chanas A 1988 Severe hypocalcaemia in AIDS patients treated with foscarnet and pentamidine. Lancet 1:1455-1456
90. Jacobson MA, Gambertoglio JG, Aweeka FT, Causey DM, Portale AA 1991 Foscarnet-induced hypocalcemia and effects of foscarnet on calcium metabolism. J Clin Endocrinol Metab 72:1130-1135
91. Shah GM, Alvarado P, Kirschenbaum MA 1990 Symptomatic hypocalcemia and hypomagnesemia with renal magnesium wasting associated with pentamidine therapy in a patient with AIDS. Am J Med 89:380-382
92. Burnett RJ, Reenta SB 1990 Severe hypomagnesemia induced by pentamidine. DICP Ann Pharmacother 24:239-240
93. Glass AR, Eil C 1988 Ketoconazole-induced reduction in serum 1, 25-dihydroxyvitamin D and total serum calcium in hypercalcemic patients. J Clin Endocrinol Metab 66:937
94. Brodie MJ, Boobis AR, Dollery CT, Hillyard CJ, Brown DJ, Macintyre I, Park BK 1980 Rifampicin and vitamin D metabolism in man [proceedings]. Br J Clin Pharmacol 9:286P-287P
95. Jaeger P, Otto S, Speck RF, Villiger L, Horber FF, Casez JP, Takkinen R 1994 Altered parathyroid gland function in severely immunocompromised patients infected with human immunodeficiency virus. J Clin Endocrinol Metab 79:1701-1705
96. Adams JS, Fernandez M, Gacad MA, Gill PS, Endres DB, Rasheed S, Singer FR 1989 Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood 73:235-239
97. Delahunt JW, Romeril KE 1994 Hypercalcemia in a patient with the acquired immunodeficiency syndrome and Mycobacterium avium intracellulare infection. J Acquir Immune Defic Syndr 7:871-872
98. Ahmed B, Jaspan JB 1993 Case report: hypercalcemia in a patient with AIDS and Pneumocysitis carinii pneumonia. Am J Med Sci 306:313-316
99. Gallis HA, Drew RH, Pickard WW 1990 Amphotericin B: 30 years of clinical experience. Rev Infect Dis 12:308
100. Farese RV, Schambelan M, Hollander H, Stringari S, Jacobson MA 1990 Nephrogenic diabetes insipidus associated with foscarnet treatment of Cytomegalovirus retinitis. Ann Intern Med 112:955-956
101. Pudney J, Anderson D 1991 Orchitis and human immunodeficiency virus type 1 infected cells in reproductive tissues from men with the acquired immune deficiency syndrome. Am J Pathol 139: 149-160
102. Dalton AD, Harcourt-Webster JN 1991 The histopathology of testes and epididymis in AIDS-a post-mortem study. J Pathol 163: 47-52
103. Chabon AB, Stenger RJ, Grabstald H 1987 Histopathology of testis in acquired immune deficiency syndrome. Urology 29:658-663
104. da Silva M, Shevchuk MM, Cronin WJ, Armenakas NA, Tannenbaum N, Fracchia JA, Ioachim HL 1990 Detection of HlV related protein in testes and prostates of patients with AIDS. Am J Clin Pathol 93:196-201
105. Reichert CM, O'Leary TJ, Levens DL, Simrell CR, Macher AM 1983 Autopsy pathology in the acquired immune deficiency syndrome. Am J Pathol 112:357-382
106. De Paepe ME, Waxman M 1989 Testicular atrophy in AIDS: a study of 57 autopsy cases. Hum Pathol 20:210-214
107. Nuovo GJ, Becker J, Simsir A, Margiotta M, Khalife G, Shevchuk M 1994 HIV-1 nucleic acids localize to the spermatogonia and their progeny. A study by polymerase chain reaction in situ hybridization. Am J Pathol 144:1142-1148
108. De Paepe ME, Guerri C, Waxman M 1990 Opportunistic infections of the testis in the acquired immune deficiency syndrome. Mt Sinai J Med 57:25-29
109. Wagner G, Rabkin JG, Rabkin R 1995 Illness stage, concurrent medications, and other correlates of low testosterone in men with HIV illness. J Acquir Immune Defic Syndr Hum Retrovirol 8:204-207
110. Lefrere JJ, Laplanche JL, Vittecoq D, Villette JM, Fiet J, Modai J, Creux C 1988 Hypogonadism in AIDS. AIDS 2:135-136
111. Croxson RS, Chapman WE, Miller KL, Levit CD, Senie R, Zumoff B 1989 Changes in the hypothalamic-pituitary-gonadal axis in human immunodeficiency virus-infected homosexual men. J Clin Endocrinol Metab 68:317-321
112. Smith CG, Asch RH 1987 Drug abuse and reproduction. Fertil Steril 48:355
113. Woolf PD, Hamill RW, McDonald JV, Lee LA, Kelly M 1985 Transient hypogonadotropic hypogonadism caused by critical illness. J Clin Endocrinol Metab 60:444-50
114. Calkins JH, Sigel MM, Nankin HR, Lin T 1988 Interleukin-1 inhibits Leydig cell steroidogenesis in primary culture. Endocrinology 123:1605-1610
115. van der Poll T, Rominjn JA, Endert E, Sauerwein HP 1993 Effects of tumor necrosis factor on the hypothalamic-pituitary-testicular axis in healthy men. Metabolism 42:303-307
116. Martin ME, Benassayag C, Amiel C, Canton P, Nunez EA 1992 Alterations in the concentrations and binding properties of sex steroid binding protein and corticosteroid-binding globulin in HIV+ patients. J Endocrinol Invest 15:597-603
117. Widy-Wirski R, Berkely S, Downing R, Okware S, Recine U, Mugerwa R, Lwegaba A, Sempala S 1988 Evaluation of the WHO clinical case definition of AIDS in Uganda. JAMA 260:3286-3289
118. Shah PN, Smith JR, Wells C, Barton SE, Kitchen VS, Steer PJ 1994 Menstrual symptoms in women infected by the human immunodeficiency virus. Obstet Gynecol 83:397-400
119. Shelton M, Adams J, Gugino L, Hewitt R, Cordaro J, Cousins S, Morese G, Menstrual cycle hormone patterns in HIV infected women. Proceedings of the 3rd Conference on Retroviruses and Opportunistic Infections. Washington DC, 1996 (Abstract 432), p 134
120. Sano T, Kovacs K, Scheithauer BW, Rosenblum MK, Petite CK, Greco CM 1989 Pituitary pathology in acquired immunodeficiency syndrome. Arch Pathol Lab Med 113:1066-1070
121. Mosca L, Costanzi G, Antonacci C, Boldorini R, Carboni N, Cristina S, Liverani C, Parravicini C, Pirolo A, Vago L 1992 Hypophyseal pathology in AIDS. Histol Histopathol 7:291-300
122. Ferreiro J, Vinters HV 1988 Pathology of the pituitary gland in patients with the acquired immune deficiency syndrome (AIDS). Pathology 20:211-215
123. Milligan SA, Katz MS, Craven PC, Strandberg DA, Russell IJ, Beckei RA 1984 Toxoplasmosis presenting as panhypopituitarism in a patient with the acquired immune deficiency syndrome. Am J Med 77:760-764
124. Sullivan WM, Kelley GG, O'Connor PG, Dickey PS, Kim JH, Robbins R, Shulman GI 1992 Hypopituitarism associated with a hypothalamic CMV infection in a patient with AIDS. Am J Med 92:221-223
125. Gorman JM, Warne PA, Begg MD, Cooper TB, Novacenko H, Williams JBW, Rabkin J, Stern Y, Ehrhardt AA 1992 Serum prolactin levels in homosexual and bisexual men with HIV infection. Am J Psychiatry 149:367-370
126. Kaufman FR, Gomperts ED 1989 Growth failure in boys with hemophilia and HIV infection. Am J Pediatr Hematol Oncol 11: 292-294
127. Schwartz LJ, St Louis Y, Wu R, Wiznia A, Rubinstein A, Saenger P 1991 Endocrine function in children with human immunodeficiency virus infection. Am J Dis Child 145:330-333
128. Matarazzo P, Palomba E, Lala R, Ciuti E, Altare F, de Sanctis L, Tovo PA 1994 Growth impairment, IGF-1 hyposecretion and thyroid dysfunction in children with perinatal HIV-1 infection. Acta Paediatr Scand 83:1029-1034
129. Hintz RL, Suskind R, Amatayakul E, Thanangkul O, Olson R 1978 Plasma somatomedin and growth hormone values in children with protein-calorie malnutrition. J Pediatr 92:153-156
130. Laue L, Pizzo PA, Butler K, Cutler GB 1990 Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome. J Pediatr 117:541-545
131. Geffner ME, Yeh DY, Landaw EM, Scott ML, Stiehm ER, Bryson YJ, Israele V 1993 In vitro insulin-like growth factor-1, growth hormone, and insulin resistance occurs in symptomatic human immunodeficiency virus-1-infected children. Pediatr Res 34:66-72
132. Salbe AD, Kotler DP, Tierney AR, Wang J, Pierson RN, Campbell RG 1995 Correlation between serum insulin-like growth factor 1 (IGF-1) concentrations and nutritional status in HIV-infected individuals. Nutr Res 15:1437-1443
133. Mulligan K, Grunfeld C, Hellerstein M, Neese RA, Schambelan M 1993 Anabolic effects of recombinant human growth hormone in patients with wasting associated with human immunodeficiency virus infection. J Clin Endocrinol Metab 77:956-962
134. Agarwal A, Soni A, Ciechanowsky M, Chander P, Treser G 1989 Hyponatremia in patients with the acquired immunodeficiency syndrome. Nephron 53:317-321
135. Tang WW, Kaptein EM, Feinstein EI, Massry SG 1993 Hyponatremia in hospitalized patients with the acquired immunodefi-ciency syndrome (AIDS) and the AIDS-related complex. Am J Med 94:169-174
136. Vitting KE, Gardenswartz MH, Zabetakis PM, Tapper ML, Gleim GW, Agrawal M, Michelis MF 1990 Frequency of hyponatremia and nonosmolar vasopressin release in the acquired immunodeficiency syndrome. JAMA 263:973-978
137. Cusano AJ, Thies HL, Siegal FP, Dreisbach AW, Maesaka JK 1990 Hyponatremia in patients with acquired immune deficiency syndrome. J Acquir Immune Defic Syndr 3:949-953
138. Choi MJ, Fernandez PC, Patnaik A, Coupaye-Gerard B, D'Andrea D, Szerlip H, Kleyman TR 1993 Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS. N Engl J Med 328: 703-706
139. Ahn Y, Goldman JM 1989 Trimethoprim-sulfamethoxazole and hyponatremia. Ann Intern Med 103:161-162
140. Madhoun ZT, DuBois DB, Rosenthal J, Findlay JC, Aron DC 1991 Central diabetes insipidus: a complication of herpes simplex type 2 encephalitis in a patient with AIDS. Am J Med 90:658-659
141. Dowell SF, Moore GW, Hutchins GM 1990 The spectrum of pancreatic pathology in patients with AIDS. Mod Pathol 3:49-53
142. Hommes MJT, Romihn JA, Endert E, Schattenkerk JKME, Sauerwein HP 1991 Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism 40:651-656
143. Heyligenberg R, Romijn JA, Hommes JT, Endert E, Schattenkerk JKME, Sauerwein HP 1993 Non-insulin-mediated glucose uptake in human immunodeficiency virus-infected men. Clin Sci 84:209-216
144. Hommes MJT, Romihn JA, Endert E, Sauerwein HP 1991 Resting energy expenditure and substrate oxidation in human immunodeficiency virus (HIV)-infected asymptomatic men: HIV affects host metabolism in the early asymptomatic stage. Am J Clin Nutr 54:311-315
145. Stein TP, Nutinsky C, Condoluci D, Schluter MD, Leskiw MJ 1990 Protein and energy substrate metabolism in AIDS patients. Metabolism 39:876-881
146. Grunfeld C, Feingold KR 1991 The metabolic effects of rumor necrosis factor and other cytokines. Biotherapy 3:143-158
147. van der Poll T, Romijin JA, Endert E, Borm JJJ, Buller HR, Sauerwein HP 1991 Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans. Am J Physiol 261: E457-E465
148. Osei K, Falko JM, Nelson KP, Stephens R 1984 Diabetogenic effect of pentamidine: in vitro and in vivo studies in a patient with malignant insulinoma. Am J Med 77:41-46
149. Bouchard PH, Sai P, Reach G, Caubarrere I, Ganeval D, Assan R 1982 Diabetes mellitus following pentamidine-induced hypoglycemia in humans. Diabetes 31:40-45
150. Waskin H, Stehr-Green JK, Helmick CG, Sattler FR 1988 Risk factors for hypoglycemia associated with pentamidine therapy for Pneumocystis pneumonia. JAMA 260:345-347
151. Stahl-Bayliss CM, Kaiman CM, Laskin OL 1986 Pentamidine-induced hypoglycemia in patients with the acquired immune deficiency syndrome. Clin Pharmacol Ther 39:271-275
152. Perronne C, Bricaire F, Leport C, Assan D, Vilde JL, Assan R 1990 Hypoglycemia and diabetes mellitus following parenteral pentamidine mesylate treatment in AIDS patients. Diabetic Med 7:585-587
153. Chen JP, Braham RL, Squires KE 1991 Diabetes after aerosolized pentamidine. Ann Intern Med 114:913-914
154. Karboski JA, Godley PJ 1988 Inhaled pentamidine and hypoglycemia. Ann Intern Med 108:490
155. Brivet FG, Naveau SH, Lemaigre GF, Dormont J 1994 Pancreatic lesions in HIV-infected patients. Baillieres Clin Endocrinol Metab 8:859-877
156. Henry K, Rathgaber S, Sullivan C, McCabe K 1992 Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia. Ann Intern Med 116:53-54
157. Feingold KR, Krauss RM, Pang M, Doerrler W, Jensen P, Grunfeld C 1993 The hypertriglyceridemia of acquired immunodeficiency syndrome is associated with an increased prevalence of low density lipoprotein subclass pattern B. J Clin Endocrinol Metab 76:1423-1427
158. Zangerle R, Sarcletti M, Gallati Reibnegger G, Wachter H, Fuchs D 1994 Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation. J Acquir Immune Defic Syndr 7:1149-1156
159. Grunfeld C, Kotler DP, Hamadeh R, Tierney A, Wang J, Pierson RN 1989 Hypertriglyceridemia in the acquired immunodeficiency syndrome. Am J Med 86:27-31
160. Mildvan D, Machado SG, Wilets I, Grossberg SE 1992 Endogenous interferon and triglyceride concentrations to assess response to zidovudine in AIDS and advanced AIDS-related complex. Lancet 339:453-456
161. Constans J, Pellegrin JL, Peuchant E, Dumon MF, Pellegrin I, Sergeant C, Simonoff M, Brossard G, Barbeau P, Fleury H, Clerc M, Leng B, Conn C 1994 Plasma lipids in HIV-infected patients: a prospective study in 95 patients. Eur J Clin Invest 24:416-420
162. Shor-Posner G, Basit A, Lu Y, Cabrejos C, Chang J, Fletcher M, Mantero-Atienza E, Baum MK 1993 Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. Am J Med 94:515-519
163. Kotler DP, Wang J, Pierson RN 1985 Studies of body composition in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr 42:1255-1265
164. Kotler DP, Tierney AR, Francisco A, Wang J, Pierson Jr RN 1989 The magnitude of body cell mass depletion determines the timing of death from wasting in AIDS. Am J Clin Nutr 50:444-447
165. Grunfeld C, Feingold KR 1992 Metabolic disturbances and wasting in the acquired immunodeficiency syndrome. N Engl J Med 327:329-337
166. Grunfeld C, Pang M, Shimizu L, Shigenaga JK, Jensen P, Feingold KR 1992 Resting energy expenditure, caloric intake, and short-term weight change in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. Am J Clin Nutr 55:455-460
167. Melchior JC, Raguin G, Boulier A, Bouvet E, Rigaud D, Matheron S, Casalino E, Vilde JL, Vachon F, Coulaud JP, Apfelbaum M 1993 Resting energy expenditure in human immunodeficiency virus-infected patients: comparison between patients with and without secondary infections. Am J Clin Nutr 57:614-619
168. Melchior JC, Salmon D, Rigaud D, Leport C, Bouvet E, Detruchis P, Vilde JL, Vachon F, Coulaud JP, Apfelbaum M 1991 Resting energy expenditure is increased in stable, malnourished HIV-infected patients. Am J Clin Nutr 53:437-441
169. Macallan DC, Noble C, Baldwin C, Jebb SA, Prentice AM, Coward WA, Sawyer MB, McManus TJ, Griffin GE 1995 Energy expenditure and wasting in human immunodeficiency virus infection. N Engl J Med 333:83-88
170. Suttmann U, Ockenga J, Hoogestraat L, Selberg O, Schedel I, Deicher H, Muller MJ 1993 Resting energy expenditure and weight loss in human immunodeficiency virus-infected patients. Metabolism 42:1173-1179
171. Macallan DC, Noble C, Baldwin C, Foskett M, McManus T, Griffin GE 1993 Prospective analysis of patterns of weight change in stage IV human immunodeficiency virus infection. Am J Clin Nutr 58:417-424
172. Kotler DP, Tierney AR, Culpepper-Morgan JA, Wang J, Pierson RN 1990 Effect of home total parenteral nutrition upon body composition in patients with AIDS. JPEN 14:454-458
173. Oster MH, Enders SR, Samuels SJ, Cone LA, Hooton TM, Browder HP, Flynn NM 1994 Megastrol acetate in patients with AIDS and cachexia. Ann Intern Med 121:400-408
174. Von Roenn JH, Armstrong D, Kotler DP, Cohn DL, Klimas NG, Tchekmedyian NS, Cone L, Brennan PJ, Weitzman SA 1994 Megastrol acetate in patients with AIDS-related cachexia. Ann Intern Med 121:393-399
175. Struwe M, Kaempfer SH, Geiger CJ, Pavia AT, Plasse TF, Shepard KV, Ries K, Evans TG 1993 Effect of dronabinol on nutritional status in HIV infection. Ann Pharmacother 27:827-830
176. Engelson ES, Pi-Sunyer FX, Kotler DP 1995 Effects of megestrol acetate therapy on body composition and circulating testosterone concentrations in patients with AIDS. AIDS 9:1107-1108
177. Hengge UR, Baumann M, Maleba R, Brockmeyer NH, Goos M 1996 Oxyrnetholone promotes weight gain in patients with advanced human immunodeficiency (HIV-1) infection. Br J Nutr 75: 129-138
178. Lieberman SA, Butterfield GE, Harrison D, Hoffman AR 1994 Anabolic effects of recombinant insulin-like growth factor-1 in cachectic patients with the acquired immunodeficiency syndrome. J Clin Endocrinol Metab 78:404-410
179. Krentz AJ, Koster FT, Crist DM, Finn K, Johnson LZ, Boyle PJ, Schade DS 1993 Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex. J Acquir Immune Defic Syndr 6:245-251
180. Schambelan M, LaMarca A, Mulligan K, Grunfeld C, Kenneth S, Breitmeyer J, Daar E 1994 Growth hormone therapy of AIDS wasting. Program of the Xth International Conference on AIDS, Yokohama, Japan, 1994, vol 2:35 (Abstract)
181. Godfried MH, Romijin JA, van der Poll T, Weverling GJ, Corssmit EPM, Endert E, Schattenkerk JKE, Sauerwein HP 1995 Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection. Metabolism 44:1564-1569
182. Godfried MH, van der Poll T, Weverling GJ, Mulder JW, Jansen J, van Deventer SJH, Sauerwein HP 1994 Soluble receptors for tumor necrosis factor as predictors of progression to AIDS in asymptomatic human immunodeficiency virus type 1 infection. J Infect Dis 169:739-745
183. Thea DM, Porat R, Nogimbi K, Baangi M, St. Louis ME, Kaplan G, Dinarello CA, Keusch GT 1996 Plasma cytokines, cytokine antagonists, and disease progression in African women infected with HIV-1. Ann Intern Med 124:757-762
184. Salehian B, Niyongabo T, Salmon D, Vilde JL, Melchior JC, Rigaud D, Kayat D, Soubrane C 1993 Tumor necrosis factor and resting energy expenditure during the acquired immunodeficiency syndrome. Am J Clin Nutr 58:715-716
185. Dezube BJ, Pardee AB, Chapman B, Beckett LA, Korvick JA, Novick WJ, Chiurco J, Kasdan P, Ahlers CM, Ecto LT, Crumpacker CS 1993 Pentoxifylline decreases tumor necrosis factor expression and serum triglycerides in people with AIDS. J Acquir Immune Defic Syndr 6:787-794
186. Landman D, Sarai A, Sathe SS 1994 Use of pentoxifylline therapy for patients with AIDS-related wasting: pilot study. Clin Infect Dis 18:97-99
187. Klausner JD, Makonkawkeyoon S, Akarasewi P, Nakata K, Kasinrerk W, Corral L, Dewar RL, Lane C, Freedman VH, Kaplan G 1996 The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection. J Acquir Immune Defic Syndr Hum Retrovirology 11:247-257